CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Spread the love In an era of rapid technological advancement, social upheaval, and environmental challenges, certain ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcus Biosciences (RCUS – Research Report), ...

Cathie Wood’s ARK ETFs capitalized on the pullback in Coinbase (COIN) and Robinhood (HOOD) stocks to load up additional shares on Thursday ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Cathie Wood‘s Ark Invest made significant trades, focusing on acquiring shares in Robinhood Markets Inc (NASDAQ:HOOD), Coinbase Global Inc (NASDAQ:COIN), and ...

Definition: Reference price is also known as competitive pricing, because here the product is sold just below the price of a competitor’s product. Reference price is the cost at which a manufacturer ...

2-Year U.S. Treasury Note Continuous Contract $103.523-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.898-0.055-0.05% 10-Year U.S. Treasury Note Continuous Contract $110.875-0.063 ...

Good afternoon, ladies and gentlemen, and thank you for joining DocuSign's fourth quarter fiscal year '25 earnings conference ...